Gene · 2071
Papers2,382
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,382
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Investigation of germline variants in Bahraini women with breast cancer using next-generation sequencing based-multigene panel. | PLoS One | 2023 | 37656691 | PubTator, text mining | PubMed |
| The Effects of Nebulized Inhaled Triptolide on Airway Inflammation in a Mouse Model of Asthma. | Can Respir J | 2023 | 37645252 | PubTator, text mining | PubMed |
| Cockayne syndrome type 3 with dystonia-ataxia and clicking blinks. | Mov Disord Clin Pract | 2023 | 37636235 | PubTator, text mining | PubMed |
| Mono- and Co-Doped Mn-Doped CsPbCl3 Perovskites with Enhanced Doping Efficiency and Photoluminescent Performance. | Materials (Basel) | 2023 | 37629836 | PubTator, text mining | PubMed |
| Multiple Sclerosis Heritability Estimation on Sardinian Ascertained Extended Families Using Bayesian Liability Threshold Model. | Genes (Basel) | 2023 | 37628630 | PubTator, text mining | PubMed |
| Oxidative DNA Damage and Repair: Mechanisms, Mutations, and Relation to Diseases. | Antioxidants (Basel) | 2023 | 37627618 | PubTator, text mining | PubMed |
| Understanding DNA Damage Response and DNA Repair in Multiple Myeloma. | Cancers (Basel) | 2023 | 37627183 | PubTator, text mining | PubMed |
| Association of ERCC family mutations with prognosis and immune checkpoint inhibitors response in multiple cancers. | Sci Rep | 2023 | 37626083 | PubTator, text mining | PubMed |
| An overview on the relationship between residential radon and lung cancer: what we know and future research. | Clin Transl Oncol | 2023 | 37610496 | PubTator, text mining | PubMed |
| Brazilian XP-E siblings carrying a novel DDB2 variant developed early-onset melanoma: a case report. | BMC Med Genomics | 2023 | 37573316 | PubTator, text mining | PubMed |
| Validation of the Idylla GeneFusion assay to detect fusions and MET exon-skipping in non-small cell lung cancers. | Sci Rep | 2023 | 37558711 | PubTator, text mining | PubMed |
| Conditional Dependency of LP-184 on Prostaglandin Reductase 1 is Synthetic Lethal in Pancreatic Cancers with DNA Damage Repair Deficiencies. | Mol Cancer Ther | 2023 | 37552607 | PubTator, text mining | PubMed |
| GATA2 co-opts TGFβ1/SMAD4 oncogenic signaling and inherited variants at 6q22 to modulate prostate cancer progression. | J Exp Clin Cancer Res | 2023 | 37550764 | PubTator, text mining | PubMed |
| Prevalence and clinical implications of germline pathogenic variants in cancer predisposing genes in young patients across sarcoma subtypes. | J Med Genet | 2023 | 37536918 | PubTator, text mining | PubMed |
| Research progress on the role and mechanism of DNA damage repair in germ cell development. | Front Endocrinol (Lausanne) | 2023 | 37529603 | PubTator, text mining | PubMed |
| Recovery of protein synthesis to assay DNA repair activity in transcribed genes in living cells and tissues. | Nucleic Acids Res | 2023 | 37522336 | PubTator, text mining | PubMed |
| A Significant Increasing Risk Association between Cigarette Smoking and XPA and XPC Genes Polymorphisms. | Genes (Basel) | 2023 | 37510255 | PubTator, text mining | PubMed |
| Preclinical Efficacy of LP-184, a Tumor Site Activated Synthetic Lethal Therapeutic, in Glioblastoma. | Clin Cancer Res | 2023 | 37494541 | PubTator, text mining | PubMed |
| Hypoxia: syndicating triple negative breast cancer against various therapeutic regimens. | Front Oncol | 2023 | 37492478 | PubTator, text mining | PubMed |
| Proliferating cell nuclear antigen inhibitors block distinct stages of herpes simplex virus infection. | PLoS Pathog | 2023 | 37486931 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2071/papers?page=7